Frontiers | Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson’s disease
1 Hospital for Special Surgery, New York, NY, United States 2 Weill Cornell Medicine, New York, NY, United States 3 The Neuro’s Early Drug Discovery Unit (EDDU), McGill University, Montreal, QC, Canada This study aimed to evaluate different combinations of three dietary supplements for potential additive or synergistic effects in an in vitro Parkinson’s Disease model. The complex and diverse processes leading to neurodegeneration in each patient with a neurodegenerative disorder cannot be effectively
